Boston ASENT Networking Reception
ASENT invites you to join us at Catalyst Restaurant in Cambridge, MA, to connect with Boston Area peers focused on drug and device development in the area of Neurotherapeutics.
You will hear from our new president Ludy Shih, MD, MMSc, and from our guest speaker Kiran Reddy, MD, MBA, Senior Managing Director in the Blackstone Life Sciences group. Kiran will share a little on his experience as a presenter at the recent ASENT Annual Meeting.
This event will take place at:
Catalyst Restaurant
300 Technology Square
Cambridge, MA 02139
6:00 - 8:00 pm
Complimentary validated parking is available in the Technology Square garage.
Drinks and Light Appetizers will be served
Join in a short moderated discussion with our guest speakers (see bios below) followed by Q&A and networking.
GUEST SPEAKERS
Kiran Reddy, MD, MBA
Kiran Reddy is a Senior Managing Director in the Blackstone Life Sciences group having joined in May 2020. Dr. Reddy was previously the President & CEO of Praxis Precision Medicines, which he co-founded in November 2016.
Previously, Dr. Reddy was at Biogen where he was part of the corporate develop and strategy leadership team. Dr. Reddy was also an Associate Partner at Third Rock Ventures. He supported and managed various portfolio companies in addition to focusing on new company formation and new investments. He was part of the founding team and interim Chief Business Officer for SAGE Therapeutics through its IPO. Dr. Reddy was part of the team that launched Foundation Medicine, and he has served as a Board Observer for Alnara pharmaceuticals, Rhythm pharmaceuticals and PanOptica pharmaceuticals.
Dr. Reddy holds MD and MBA degrees from Georgetown University. He completed his internship in medicine and his neurology residency at Harvard/Massachusetts General Hospital. Dr. Reddy was previously a Howard Hughes science fellow and has authored several peer-reviewed scientific papers in the field of epilepsy, neuroimmunology and neurodegenerative diseases.
Ludy Shih, M.D., M.M.Sc.
Dr. Ludy Shih received her MD from the University of California School of Medicine, Los Angeles and completed her internship, neurology residency, and movement disorders fellowship at Harvard Medical School/Beth Israel Deaconess Medical Center (BIDMC) and completed a master’s in clinical investigation through the Harvard-MIT Health Sciences and Technology Clinical Investigator Training Program. She has been an active clinical investigator in Parkinson's disease and essential tremor throughout her career. In addition, she worked at Biogen and Vertex Pharmaceuticals in early stage clinical development, designing studies for Parkinson's disease and genetic movement disorders. She is a Fellow of the American Academy of Neurology, and the American Neurological Association, and serves as Associate Editor at Annals of Clinical and Translational Neurology. She has been as a member of ASENT since 2017 and has served as a member as well as co-chair of the Scientific Program Committee and currently serves as ASENT’s President.
Jessica K. Smith
Jessica Keenan Smith is Executive Director of the American Society for Experimental Neurotherapeutics (ASENT), an organization that brings together leaders from industry, academia, government and advocacy who are engaged in bringing drugs and devices to market across all neurologic disease states. Ms. Smith is also Founder and CEO of Living Well With Epilepsy, an online platform that provides in-depth information on epilepsy to those living with the disease and their loved ones. By holding both these roles simultaneously, she bridges the gap between the scientific and patient communities. As an award-winning professional with more than two decades of experience in healthcare, higher education and nonprofit sectors, Ms. Smith has led organizations to achieve outstanding results.
